LinkLive Expands Partnership with Kasisto, Conversational AI
SAN FRANCISCO–(BUSINESS WIRE)–LinkLive, a leading cloud-based Contact Center as a Service (CCaaS) provider, has partnered…
Month: March 2023
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nutanix, Inc. (NTNX) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Sunrise Raises €17 Million and Aims to Increase Its Size Tenfold Within 5 Years
NAMUR, Belgium–(BUSINESS WIRE)–Sunrise, the company revolutionising home sleep testing, announces a €17 million in funding….
Jason Hanson to Succeed Diane Offereins as Executive Vice President, President of Payment Services for Discover Financial Services
RIVERWOODS, Ill.–(BUSINESS WIRE)–Discover Financial Services (NYSE: DFS) today announced that Jason Hanson will succeed…
Faraday Future Plans to Host a Special Meeting of Stockholders on March 30th, 2023, Announces Plans for Additional $50 Million Offering to Existing Shareholders
Affirmative vote required on March 30, 2023 special meeting of stockholders in order for the…
Qualtrics Announces 2023 XM Breakthrough Artist Awards, Recognizing Brands Creating Revolutionary Experiences
Experience leaders from world’s top brands – including Disney, Chipotle, and Delta – are using…
Guess?, Inc. Announces Participation at the UBS Global Consumer and Retail Conference
LOS ANGELES–(BUSINESS WIRE)–Guess?, Inc. (NYSE: GES) announced today that the Company will be participating in…
MediciNova Announces Additional Extension of BARDA Contract to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury
LA JOLLA, Calif., March 09, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
BioSyent Schedules Q4 and Full Year 2022 Earnings Release for March 21, 2023
MISSISSAUGA, Ontario, March 09, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…
Atlas Global Brands Provides Corporate Update on Integration Activities Estimated to Generate $2.5M in Annualized Savings
Atlas Global Brands today announced that it has completed most of its key integration activities…
Eagle Pharmaceuticals to Present at the Barclays Global Healthcare Conference
WOODCLIFF LAKE, N.J., March 09, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
– On Track to Provide Initial Clinical Data from Gene Editing Trial for PKU Mid-Year with…
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
— Preliminary data from GRANITE Phase 2/3 study (individualized vaccine for first-line microsatellite-stable colorectal cancer…
CymaBay Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
NEWARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
– Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2…
Histogen Reports Year-End 2022 Results and Provides Business Update
Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases SAN DIEGO,…
Aptose to Report Fourth Quarter and Full Year 2022 Financial Results and Hold Conference Call on Thursday, March 23, 2023
SAN DIEGO and TORONTO, March 09, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO;…
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2022 Financial Results
SOUTH SAN FRANCISCO, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2022 Financial Results
– Positive data from bexotegrast INTEGRIS-IPF 320 mg dose group demonstrated a continued favorable safety…